Liom Health AG
Non-invasive glucose monitoring. The ultimate wearable.
LIOM aims to provide the worlds first non-invasive precision glucose measurements with a wearable, integrating other health metrics. Tracking small irregularities in glucose metabolism can help prevent disease early.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
06.12.2024
Liom secures $25 million to advance its non-invasive glucose monitoring device (startupticker.ch)
16.05.2024
Startups restructure executive roles (startupticker.ch)
09.01.2024
Fresh funding and new executives to accelerate Spiden's product launch (startupticker.ch)
09.01.2024
Fresh funding and new executives to accelerate Spidens’s product launch (startupticker.ch)
27.01.2022
ZKB Pionierpreises Technopark: Nominierte sind bekannt (startupticker.ch)
01.03.2021
Multiple biomarkers and drugs successfully measured through light only
01.09.2020
Proprietary, multimodal and fully automated spectroscope built
01.05.2020
First proprietary micro chip taped out
01.09.2019
Spectral, chemical and opto-electronic laboratories ramped up
01.09.2018
First employee joined, R&D workstreams established
No Jobs
No videos and documents
No Awards
Liom Health AG
Non-invasive glucose monitoring. The ultimate wearable.
Website:
liom.com/
Headquarter:
Pfäffikon SZ
Foundation Date:
December 2017
Technology:
- Medtech
Sectors:
- Medtech